The decrease in ghrelin concentration following AGE-D in this study was paralleled by a massive increase in the plasma levels of PAI-1, a key regulator of vascular remodeling, involved in various thrombotic diseases such as deep vein thrombosis, ischemic heart disease and diabetic vascular complications. Here, GHRL is linked to thrombotic disease.